A study to characterize adherence levels and to compare the ability of adherence measures (TFV-DP/FTC or TAF/FTC) to distinguish Young adults with perinatal HIV-infection (YAPHIV) with viral suppression
Latest Information Update: 06 Apr 2020
At a glance
- Drugs Emtricitabine/tenofovir alafenamide (Primary) ; Emtricitabine/tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Therapeutic Use
Most Recent Events
- 06 Apr 2020 New trial record
- 11 Mar 2020 Results presented at the 27th Conference on Retroviruses and Opportunistic Infections